Prelude Therapeutics shares owned by Jacobs Levy Equity Management
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Jacobs Levy Equity Management
from 13F filings
Historical chart of Jacobs Levy Equity Management investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Prelude Therapeutics by Jacobs Levy Equity Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $561k | 131k | 4.27 |
2023-09-30 | $445k | 144k | 3.09 |
2023-06-30 | $524k | 117k | 4.50 |
2023-03-31 | $483k | 85k | 5.70 |
2021-12-31 | $1.6M | 130k | 12.45 |
More positions owned by Jacobs Levy Equity Management
View all positions for Jacobs Levy Equity Management